Ask Our Doctors and Nurses!

KALETRA Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

KALETRA Safety Reports

Total KALETRA reports: 422.
KALETRA FDA safety alerts: 2003 2007 .
Reported deaths: 84    Reported hospitalizations: 252.
Take KALETRA Side Effects Survey or Share Your KALETRA Story. Read More Here.

Showing 1-75 of 422 Next >

Consumer or non-health professional from UNITED STATES reported KALETRA problem on Mar 09, 2007. Male patient, weighting 226.4 lb, was diagnosed with hiv infection, hypertriglyceridaemia, pain, hypertension, ischaemic heart disease prophylaxis and was treated with KALETRA. KALETRA dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, PROPACET, DILTIAZEM HYDROCHLORIDE, METOPROLOL SUCCINATE, ACETYLSALICYLIC ACID SRT, HYZAAR, AMLODIPINE BESYLATE. Patient died on 01/04/2007.

KALETRA problem was reported by a Physician from GERMANY on Mar 12, 2007. Male patient, weighting 114.6 lb, was diagnosed with hiv infection, candidiasis, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, disseminated tuberculosis, gastrointestinal disorder, immune reconstitution syndrome, pyrexia, weight decreased. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, FLUCONAZOLE, BACTRIM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported KALETRA problem on Mar 20, 2007. Male patient, 50 years of age, weighting 147.7 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: dyspepsia, incorrect dose administered, stomach discomfort. KALETRA dosage: unknown. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 14, 2007. Female patient was diagnosed with prophylaxis against hiv infection, episiotomy and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neutropenia, procedural pain. KALETRA dosage: 400/100 MG. During the same period patient was treated with LAMIVUDINE, AMOXICILLIN TRIHYDRATE. Patient recovered.

Physician from UNITED STATES reported KALETRA problem on Mar 12, 2007. Female patient, 28 years of age, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: road traffic accident. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.

KALETRA problem was reported by a Physician from FRANCE on Mar 15, 2007. Female patient, 48 years of age, weighting 136.7 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: electrocardiogram pr prolongation, malaise. KALETRA dosage: unknown. During the same period patient was treated with BACTRIM, CLONAZEPAM, GABAPENTIN, ABACAVIR SULPHATE LAMIVUDINE AND ZIDOVUDINE. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported KALETRA problem on Mar 15, 2007. Male patient, weighting 154.3 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: asthenia, erythema, hepatotoxicity, platelet aggregation decreased, prothrombin level increased, transaminases increased. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, LAMIVUDINE, BACTRIM. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Physician from MEXICO on Mar 21, 2007. Male patient, weighting 118.6 lb, was diagnosed with hiv test positive, hiv infection, prophylaxis against gastrointestinal ulcer, pneumocystis jiroveci pneumonia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: lymphadenitis, lymphadenopathy, pancytopenia. KALETRA dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, OMEPRAZOLE, BACTRIM. Patient was hospitalized. Patient recovered.

Physician from MEXICO reported KALETRA problem on Mar 21, 2007. Male patient, weighting 89.29 lb, was diagnosed with hiv infection, prophylaxis against gastrointestinal ulcer, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, cholangitis, diarrhoea, malaise, perianal abscess, pyrexia, septic shock. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, OMEPRAZOLE, BACTRIM. Patient died on 02/27/2007.

KALETRA problem was reported by a Health Professional from FRANCE on Mar 16, 2007. Male patient, 32 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: dermatitis allergic, skin exfoliation. KALETRA dosage: unknown. During the same period patient was treated with ABACAVIR, ZOLPIDEM. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported KALETRA problem on Mar 19, 2007. Male patient, weighting 6.45 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: trisomy 21. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, LAMIVUDINE, EFAVIRENZ, ZIDOVUDINE. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 19, 2007. Male patient, weighting 150.4 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: pleural effusion. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

Physician from MEXICO reported KALETRA problem on Mar 26, 2007. Male patient, weighting 89.29 lb, was diagnosed with hiv infection, prophylaxis against gastrointestinal ulcer, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, cholangitis, diarrhoea, malaise, perianal abscess, pyrexia, septic shock. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, OMEPRAZOLE, BACTRIM. Patient died on 02/27/2007.

KALETRA problem was reported by a Physician from MEXICO on Mar 26, 2007. Male patient, weighting 137.8 lb, was diagnosed with hiv infection, onychomycosis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, infrequent bowel movements, vomiting. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED KINGDOM reported KALETRA problem on Mar 21, 2007. Male patient, 50 years of age, weighting 154.3 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: herpes zoster multi-dermatomal, lactic acidosis, post herpetic neuralgia, renal failure acute, therapeutic agent toxicity, vomiting. KALETRA dosage: unknown. During the same period patient was treated with LOPINAVIR, VIREAD, ZIDOVUDINE, DIDANOSINE. Patient was hospitalized. Patient died on 12/30/2005.

KALETRA problem was reported by a Physician from MEXICO on Mar 26, 2007. Male patient, weighting 118.6 lb, was diagnosed with hiv test positive, hiv infection, prophylaxis against gastrointestinal ulcer, pneumocystis jiroveci pneumonia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: lymphadenitis, lymphadenopathy, pancytopenia. KALETRA dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, OMEPRAZOLE, BACTRIM. Patient was hospitalized. Patient recovered.

Health Professional from CHILE reported KALETRA problem on Mar 22, 2007. Male patient, weighting 119.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, weight decreased. KALETRA dosage: 800MG / 200MG. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Pharmacist from UNITED KINGDOM on Mar 21, 2007. Male patient, 50 years of age, weighting 154.3 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: herpes zoster multi-dermatomal, lactic acidosis, post herpetic neuralgia, renal failure acute, therapeutic agent toxicity, vomiting. KALETRA dosage: unknown. During the same period patient was treated with LOPINAVIR, VIREAD, ZIDOVUDINE, DIDANOSINE. Patient was hospitalized. Patient died on 12/30/2005.

Consumer or non-health professional from SWITZERLAND reported KALETRA problem on Mar 27, 2007. Female patient, 33 years of age, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. KALETRA dosage: 133.3 / 33.3 MG, SIX DAILY. During the same period patient was treated with LAMIVUDINE, METHADONE, AMITRIPTYLINE, DIAZEPAM. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 29, 2007. Male patient, weighting 150.4 lb, was diagnosed with hiv infection, insomnia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: pneumothorax. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, TEMAZEPAM. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported KALETRA problem on Mar 28, 2007. Male patient, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: constipation, subileus. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Physician from CANADA on Mar 27, 2007. Male patient, weighting 118.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: legal problem, radius fracture, ulna fracture. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported KALETRA problem on Mar 29, 2007. Male patient, weighting 1.34 lb, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: premature baby. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, LEXIVA, ZIDOVUDINE, TRUVADA, NEVIRAPINE. Patient recovered.

KALETRA problem was reported by a Health Professional from UNITED STATES on Mar 29, 2007. Male patient, weighting 1.30 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage neonatal, patent ductus arteriosus, premature baby. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, LEXIVA, ZIDOVUDINE, TRUVADA. Patient died on 03/15/2007.

Health Professional from UNITED STATES reported KALETRA problem on Apr 09, 2007. Female patient, 30 years of age, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, VITAMIN B COMPLETE, ASCORBIC ACID, STOP ITCH CREAM. Patient recovered.

KALETRA problem was reported by a Health Professional from UNITED STATES on Apr 05, 2007. Male patient, weighting 1.30 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage neonatal, patent ductus arteriosus, premature baby. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, LEXIVA, ZIDOVUDINE, TRUVADA. Patient died on 03/15/2007.

Health Professional from UNITED STATES reported KALETRA problem on Apr 02, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: placental disorder, pregnancy with advanced maternal age, stillbirth. KALETRA dosage: unknown. During the same period patient was treated with VIREAD, NEVIRAPINE, METRONIDAZOLE. Patient recovered.

KALETRA problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Female patient, 27 years of age, was diagnosed with systemic antiviral treatment and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.

Health Professional from UNITED STATES reported KALETRA problem on Apr 04, 2007. Male patient, weighting 7.43 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, ZIDOVUDINE W, NELFINAVIR MESILATE. Patient recovered.

KALETRA problem was reported by a Physician from MEXICO on Apr 11, 2007. Male patient, weighting 105.8 lb, was diagnosed with hiv infection, prophylaxis, toxoplasmosis, pyrexia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: diplopia, escherichia infection, eyelid ptosis, iiird nerve paralysis, lung neoplasm, nausea, pneumonia, vomiting. KALETRA dosage: 400MG/100MG. During the same period patient was treated with TRIMETROPRIM, FLUCONAZOLE, CLINDAMYCIN, PIRIMETAMINE, FOLINIC ACID, METAMIZOL, SULFAMETHOXAZOLE. Patient was hospitalized. Patient died on 01/25/2007.

Physician from MEXICO reported KALETRA problem on Apr 11, 2007. Male patient, weighting 89.29 lb, was diagnosed with hiv infection, prophylaxis against gastrointestinal ulcer, antifungal prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anaemia, cholangitis, diarrhoea, malaise, perianal abscess, pyrexia, septic shock. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ABACAVIR, OMEPRAZOLE, BACTRIM. Patient died on 02/27/2007.

KALETRA problem was reported by a Health Professional from FRANCE on Apr 12, 2007. Female patient, 45 years of age, weighting 145.5 lb, was diagnosed with hiv infection, toxoplasmosis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: amaurosis fugax, headache, hyperhidrosis, nystagmus. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL, TENOFOVIR DISOPROXIL, CALCIUM FOLINATE, PYRIMETHAMINE, METHADONE, SAQUINAVIR. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported KALETRA problem on Apr 12, 2007. Female patient, 53 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, epistaxis, uterine haemorrhage. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ. Patient recovered.

KALETRA problem was reported by a Physician from FRANCE on Apr 12, 2007. Male patient, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: constipation, subileus. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Health Professional from SWEDEN reported KALETRA problem on Apr 13, 2007. Female patient, 21 years of age, was diagnosed with prophylaxis against hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient, 30 years of age, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with TENOVIR, LAMIVUDINE, VITAMIND B COMPLETE, ASCORBIC ACID, STOP ITCH. Patient recovered.

Health Professional from SPAIN reported KALETRA problem on Apr 20, 2007. Male patient, 74 years of age, was diagnosed with hiv infection, prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: renal failure acute. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, BACTRIM. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from FRANCE on Apr 20, 2007. Male patient, weighting 183.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, convulsion, syncope vasovagal. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported KALETRA problem on Apr 24, 2007. Male patient, weighting 7.43 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, NELFINAVIR MESILATE, ZIDOVUDINE. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2007. Female patient, 27 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: pre-eclampsia. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported KALETRA problem on Apr 24, 2007. Female patient, weighting 4.80 lb, was diagnosed with blood hiv rna and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anion gap decreased, blood potassium increased, bradycardia, electroencephalogram abnormal, haemoglobin decreased, incorrect dose administered, malaise, neonatal respiratory arrest. KALETRA dosage: unknown. During the same period patient was treated with RITONAVIR, LAMIVUDINE, ABACAVIR. Patient was hospitalized. Patient died on 04/07/2007.

KALETRA problem was reported by a Physician from ISRAEL on Apr 25, 2007. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: completed suicide. KALETRA dosage: 100/400MG BID. Patient died.

Health Professional from UNITED STATES reported KALETRA problem on Apr 27, 2007. Male patient, weighting 4.94 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: congenital anomaly. KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, TENOFOVIR. Patient recovered.

KALETRA problem was reported by a Physician from AUSTRALIA on Apr 27, 2007. Male patient, weighting 158.7 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: varicella. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from MEXICO reported KALETRA problem on May 04, 2007. Male patient, weighting 118.6 lb, was diagnosed with hiv test positive, hiv infection, prophylaxis against gastrointestinal ulcer, pneumocystis jiroveci pneumonia and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: histiocytosis haematophagic, lymph node tuberculosis, lymphadenitis, lymphadenopathy, neutropenia, pancytopenia, pneumocystis jiroveci pneumonia, pyrexia. KALETRA dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, OMEPRAZOLE, BACTRIM. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Consumer or non-health professional from FINLAND on May 09, 2007. Male patient, weighting 169.8 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: inguinal hernia. KALETRA dosage: 400/100 MG. During the same period patient was treated with LAMIVUDINE, CETIRIZINE HYDROCHLORIDE, TEMAZEPAM, BETAMETHASONE, ASYCIONE, IMOCIX, IBUPROFEN. Patient was hospitalized. Patient recovered.

Physician from BELGIUM reported KALETRA problem on Apr 30, 2007. Male patient, weighting 205.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, diarrhoea, eating disorder, fatigue, headache, inflammation, myalgia, photophobia, pneumonia bacterial. KALETRA dosage: unknown. During the same period patient was treated with EMTRIVA, REYATAZ. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Physician from BRAZIL on May 03, 2007. Female patient, 53 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage, dysthymic disorder, epistaxis, uterine haemorrhage. KALETRA dosage: unknown. During the same period patient was treated with TENOFOVIR, LAMIVUDINE, EFAVIRENZ. Patient recovered.

Consumer or non-health professional from FRANCE reported KALETRA problem on May 03, 2007. Male patient, weighting 183.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Physician from AUSTRALIA on May 02, 2007. Male patient, weighting 158.7 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cough, syphilis. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from IRELAND reported KALETRA problem on May 03, 2007. Male patient, weighting 165.3 lb, was diagnosed with hiv infection, depression, nephrolithiasis, blood testosterone decreased and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dysphagia, eyelid ptosis, folliculitis, headache, meningism, paralysis, pyrexia, rhinitis. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, PROTHIPENDYL HYDROCHLORIDE, FUROSEMIDE, ENDRONAX, TESTOSTERONE. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Health Professional from UNITED STATES on May 04, 2007. Female patient, weighting 7.21 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hip dysplasia. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.

Health Professional from UNITED STATES reported KALETRA problem on May 10, 2007. Male patient, weighting 4.68 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hydrocephalus. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR, ZIDOVUDINE. Patient recovered.

KALETRA problem was reported by a Health Professional from UNITED STATES on May 08, 2007. Female patient, 31 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with DIDANOSINE, EFAVIRENZ. Patient recovered.

Consumer or non-health professional from BOTSWANA reported KALETRA problem on May 14, 2007. Male patient was diagnosed with prophylaxis against hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neonatal aspiration, neonatal respiratory distress syndrome. KALETRA dosage: LOPINAVIR 133.3 MILLIGRAM/RITONAVIR 33.3 MILLIGRAM. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE. Patient was hospitalized. Patient died on 04/24/2007.

KALETRA problem was reported by a Physician from UNITED KINGDOM on May 08, 2007. Male patient, weighting 4.28 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, congenital choroid plexus cyst, kidney malformation, premature baby. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE W. Patient recovered.

Physician from FRANCE reported KALETRA problem on May 10, 2007. Male patient, 25 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hepatitis, transaminases increased. KALETRA dosage: unknown. During the same period patient was treated with ABACAVIR, EMTRICITABINE. Patient recovered.

KALETRA problem was reported by a Health Professional from FRANCE on May 10, 2007. Male patient, 31 years of age, weighting 138.9 lb, was diagnosed with hiv infection, renal transplant and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose. KALETRA dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.

Physician from CZECH REPUBLIC reported KALETRA problem on May 10, 2007. Male patient, weighting 174.2 lb, was diagnosed with hiv infection cdc category c3, thrombocytopenia, prophylaxis, myocardial ischaemia, polyneuropathy and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cardiac failure, muscle injury, pulmonary oedema. KALETRA dosage: unknown. During the same period patient was treated with EMTRIVA, VIERAD, MEGESTROL ACETATE, CLARITHROMYCIN, ISOSORBIDE MONONITRATE, ACIDUM FOLICUM, PYRIDOXINE HYDROCHLORIDE. Patient died on 01/30/2007.

KALETRA problem was reported by a Physician from GERMANY on May 11, 2007. Male patient, weighting 161.2 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, alcoholism, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE W, ZIDOVUDINE W. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from FRANCE reported KALETRA problem on May 15, 2007. Male patient, 35 years of age, weighting 147.7 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease. KALETRA dosage: unknown. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Physician from BRAZIL on May 17, 2007. Male patient, 53 years of age, weighting 130.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anal haemorrhage. KALETRA dosage: unknown. During the same period patient was treated with ZIDOVUDINE, DIDANOSINE. Patient recovered.

Physician from ROMANIA reported KALETRA problem on May 14, 2007. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: acquired immunodeficiency syndrome, acute hepatic failure, bacterial sepsis, cachexia, cardiopulmonary failure, hepatomegaly, mycoplasma infection, pneumocystis jiroveci pneumonia. KALETRA dosage: unknown. During the same period patient was treated with TRIZIVIR. Patient was hospitalized. Patient died on 04/14/2007.

KALETRA problem was reported by a Physician from FRANCE on May 22, 2007. Male patient, 25 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hepatitis, transaminases increased. KALETRA dosage: unknown. During the same period patient was treated with ABACAVIR, EMTRICITABINE. Patient recovered.

Physician from ROMANIA reported KALETRA problem on May 23, 2007. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: acquired immunodeficiency syndrome, bacterial sepsis, cachexia, cardiopulmonary failure, hepatic failure, hepatomegaly, pneumocystis jiroveci pneumonia, pyrexia, renal failure acute. KALETRA dosage: unknown. During the same period patient was treated with TRIZIVIR. Patient was hospitalized. Patient died on 04/14/2007.

KALETRA problem was reported by a Physician from GERMANY on May 21, 2007. Male patient, weighting 134.5 lb, was diagnosed with hiv infection, prophylaxis and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: bronchitis, cachexia. KALETRA dosage: unknown. During the same period patient was treated with TRUVADA, METHADONE HYDROCHLORIDE, COTRIM DS. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KALETRA problem on May 23, 2007. Female patient, 30 years of age, weighting 194.0 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. KALETRA dosage: unknown. During the same period patient was treated with TENOVIR, LAMIVUDINE, VITAMIND B COMPLETE, ASCORBIC ACID, STOP ITCH. Patient recovered.

KALETRA problem was reported by a Health Professional from SWEDEN on May 24, 2007. Male patient, 47 years of age, was diagnosed with hiv infection, epilepsy and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: pancytopenia, sepsis. KALETRA dosage: unknown. During the same period patient was treated with HERMOLEPSIN, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Health Professional from CHILE reported KALETRA problem on May 22, 2007. Male patient was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, loss of consciousness, prothrombin time abnormal, transaminases abnormal. KALETRA dosage: 400/100 MG. Patient died on 04/17/2007.

KALETRA problem was reported by a Health Professional from UNITED STATES on May 24, 2007. Male patient, weighting 4.68 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: hydrocephalus. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR, ZIDOVUDINE. Patient recovered.

Health Professional from FRANCE reported KALETRA problem on May 24, 2007. Male patient, 41 years of age, weighting 138.9 lb, was diagnosed with hiv infection, renal transplant and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anuria, chest pain, confusional state, disorientation, flatulence, hypertension, oliguria. KALETRA dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Physician from UNITED KINGDOM on May 25, 2007. Male patient, weighting 4.28 lb, was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, congenital choroid plexus cyst, kidney malformation, premature baby. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE AND ZIDOVUDINE. Patient recovered.

Physician from CHILE reported KALETRA problem on May 25, 2007. Male patient, weighting 130.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anorectal infection, pneumococcal bacteraemia, pyrexia, rectal discharge, sepsis. KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.

KALETRA problem was reported by a Pharmacist from UNITED KINGDOM on May 25, 2007. Female patient, 40 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral, partial seizures, petit mal epilepsy. KALETRA dosage: unknown. During the same period patient was treated with NORVIR, TRUVADA, ATAZANAVIR SULPHATE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported KALETRA problem on May 29, 2007. Male patient, weighting 108.0 lb, was diagnosed with hiv test positive and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: failure to thrive. KALETRA dosage: 50/200MG. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, RIFABUTIN, CLARITHROMYCIN, MOXIFLOXACIN HYDROCHLORIDE, ESCITALOPRAM OXALATE, PROCRIT, BACTRIM. Patient was hospitalized. Patient recovered.

Showing 1-75 of 422 Next >